Skip to content

Low-dose aspirin in preventing preterm labor

Investigating the effect of low-dose aspirin in preventing spontaneous preterm labor

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250203064629N1
Enrollment
100
Registered
2025-02-15
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labor. Preterm labor

Interventions

Intervention 1: Intervention group: Aspirin was administered at a dose of 80 mg daily from the 16th week of pregnancy to the 36th week or until delivery, once a day. The drug was manufactured by Jalin

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Informed consent Age between 18 and 40 years Singleton pregnancy

Exclusion criteria

Exclusion criteria: Allergy to aspirin Diabetes High blood pressure

Design outcomes

Primary

MeasureTime frame
Preterm labor. Timepoint: After delivery. Method of measurement: History taking and case study.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasimsadat Mirbagheri

Esfahan University of Medical Sciences

nasimmirbagheri@gmail.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026